AGP Executive Report
Last update: 24 minutes agoEmerging Infection: France has reported the first known human Shamonda virus infection; the patient, who had a serious underlying illness, died, but investigators have not established whether the virus contributed. The virus has spread among livestock in Italy and other European countries; officials say there is no identified risk to the general public. Italian Pharma: Menarini has struck a global deal to develop GIM-621, an experimental cancer immunotherapy. The preclinical-stage drug could bring its developer up to $1.1 billion plus royalties. Clinical Research: Milan-based Newron completed enrollment of 618 people in a Phase 3 trial of evenamide for treatment-resistant schizophrenia, with results expected in early 2027. Pope’s Recovery: Pope Leo’s doctors say he needs no further treatment after lung cancer surgery; he has resumed public appearances. Cancer Care: A Rome hospital is bringing art and cultural activities into care for cancer patients.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
